Caribou Biosciences Inc [CRBU] stock is trading at $1.89, up 3.85%. An important factor to consider is whether the stock is rising or falling in short-term value. The CRBU shares have gain 3.28% over the last week, with a monthly amount glided 7.08%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Caribou Biosciences Inc [NASDAQ: CRBU] stock has seen the most recent analyst activity on June 03, 2024, when Evercore ISI downgraded its rating to a In-line and also revised its price target to $3 from $13. On October 31, 2023, Evercore ISI initiated with a Outperform rating and assigned a price target of $13 on the stock. Truist started tracking the stock assigning a Buy rating and suggested a price target of $23 on July 11, 2023. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $22 as its price target on February 18, 2022. Oppenheimer started tracking with a Outperform rating for this stock on December 01, 2021, and assigned it a price target of $36. In a note dated November 30, 2021, H.C. Wainwright initiated an Buy rating and provided a target price of $28 on this stock.
Caribou Biosciences Inc [CRBU] stock has fluctuated between $1.50 and $8.33 over the past year. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Caribou Biosciences Inc [NASDAQ: CRBU] shares were valued at $1.89 at the most recent close of the market. An investor can expect a potential return of 58.73% based on the average CRBU price forecast.
Analyzing the CRBU fundamentals
Caribou Biosciences Inc [NASDAQ:CRBU] reported sales of 33.11M for the trailing twelve months, which represents a drop of -7.75%. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at -4.28%, Pretax Profit Margin comes in at -3.72%, and Net Profit Margin reading is -3.73%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -0.35 and Total Capital is -0.41. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.8117 points at the first support level, and at 1.7333 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9567, and for the 2nd resistance point, it is at 2.0233.
Ratios To Look Out For
For context, Caribou Biosciences Inc’s Current Ratio is 8.75. On the other hand, the Quick Ratio is 8.75, and the Cash Ratio is 1.22. Considering the valuation of this stock, the price to sales ratio is 5.16, the price to book ratio is 0.55.
